Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.

Milton DT, Riely GJ, Azzoli CG, Gomez JE, Heelan RT, Kris MG, Krug LM, Pao W, Pizzo B, Rizvi NA, Miller VA
Cancer. 2007 110 (3): 599-605

PMID: 17577220 · DOI:10.1002/cncr.22816

MeSH Terms (17)

Adenocarcinoma Aged Antineoplastic Combined Chemotherapy Protocols Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Dose-Response Relationship, Drug Everolimus Female Gefitinib Humans Lung Neoplasms Male Middle Aged Quinazolines Sirolimus Survival Rate United States

Connections (1)

This publication is referenced by other Labnodes entities: